The GST Council has reduced the tax rate on specific cancer drugs and helicopter travel on a ‘seat-share basis’ to 5%, while lowering the levy on namkeen from 18% to 12%. It also agreed to exempt R&D funded by private and public sources from GST. Discussions on health insurance tax reductions were deferred.